HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$2.47
Day range
$2.22 - $2.42
Year range
$1.64 - $9.38
Market cap
885.24M USD
Avg Volume
17.53M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 67.46M | 15.20% |
Operating expense | 118.74M | 2.27% |
Net income | -91.25M | -9.23% |
Net profit margin | -135.28 | 5.18% |
Earnings per share | -0.25 | 10.71% |
EBITDA | -81.00M | 0.62% |
Effective tax rate | 2.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 300.80M | -24.32% |
Total assets | 904.95M | -8.69% |
Total liabilities | 202.66M | -6.89% |
Total equity | 702.29M | — |
Shares outstanding | 396.97M | — |
Price to book | 1.36 | — |
Return on assets | -24.76% | — |
Return on capital | -29.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -91.25M | -9.23% |
Cash from operations | -78.70M | -33.45% |
Cash from investing | 17.01M | 134.86% |
Cash from financing | 88.06M | 109.89% |
Net change in cash | 25.69M | 139.78% |
Free cash flow | -52.92M | -121.55% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
838
